These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of prenatal glucocorticoids on cerebral vasculature of the developing brain. Vinukonda G; Dummula K; Malik S; Hu F; Thompson CI; Csiszar A; Ungvari Z; Ballabh P Stroke; 2010 Aug; 41(8):1766-73. PubMed ID: 20616316 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor. Tuccillo C; Romano M; Troiani T; Martinelli E; Morgillo F; De Vita F; Bianco R; Fontanini G; Bianco RA; Tortora G; Ciardiello F Clin Cancer Res; 2005 Feb; 11(3):1268-76. PubMed ID: 15709198 [TBL] [Abstract][Full Text] [Related]
4. Paucity of pericytes in germinal matrix vasculature of premature infants. Braun A; Xu H; Hu F; Kocherlakota P; Siegel D; Chander P; Ungvari Z; Csiszar A; Nedergaard M; Ballabh P J Neurosci; 2007 Oct; 27(44):12012-24. PubMed ID: 17978043 [TBL] [Abstract][Full Text] [Related]
5. ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. McCarty MF; Wey J; Stoeltzing O; Liu W; Fan F; Bucana C; Mansfield PF; Ryan AJ; Ellis LM Mol Cancer Ther; 2004 Sep; 3(9):1041-8. PubMed ID: 15367698 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model. Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425 [TBL] [Abstract][Full Text] [Related]
7. Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. Dovizio M; Tacconelli S; Ricciotti E; Bruno A; Maier TJ; Anzellotti P; Di Francesco L; Sala P; Signoroni S; Bertario L; Dixon DA; Lawson JA; Steinhilber D; FitzGerald GA; Patrignani P J Pharmacol Exp Ther; 2012 Apr; 341(1):242-50. PubMed ID: 22262921 [TBL] [Abstract][Full Text] [Related]
9. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib. Liu J; Wu J; Zhou L; Pan C; Zhou Y; Du W; Chen JM; Zhu X; Shen J; Chen S; Liu RY; Huang W Oncotarget; 2015 Aug; 6(25):21341-52. PubMed ID: 26050198 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L; Chen W; Xie X; He Y; Bai X Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239 [TBL] [Abstract][Full Text] [Related]
13. Development of integrins in the vasculature of germinal matrix, cerebral cortex, and white matter of fetuses and premature infants. Dummula K; Vinukonda G; Xu H; Hu F; Zia MT; Braun A; Shi Q; Wolk J; Ballabh P J Neurosci Res; 2010 May; 88(6):1193-204. PubMed ID: 19960540 [TBL] [Abstract][Full Text] [Related]
14. Characterization of germinal matrix hemorrhage in extremely premature infants: recognition of posterior location and diagnostic pitfalls. Snyder EJ; Pruthi S; Hernanz-Schulman M Pediatr Radiol; 2022 Jan; 52(1):75-84. PubMed ID: 34528114 [TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Wu W; Onn A; Isobe T; Itasaka S; Langley RR; Shitani T; Shibuya K; Komaki R; Ryan AJ; Fidler IJ; Herbst RS; O'Reilly MS Mol Cancer Ther; 2007 Feb; 6(2):471-83. PubMed ID: 17308046 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Ciardiello F; Caputo R; Damiano V; Caputo R; Troiani T; Vitagliano D; Carlomagno F; Veneziani BM; Fontanini G; Bianco AR; Tortora G Clin Cancer Res; 2003 Apr; 9(4):1546-56. PubMed ID: 12684431 [TBL] [Abstract][Full Text] [Related]
17. [Effect of sutent and celecoxib on the properties of endothelial cells in vitro]. Liamina IV; Starikova EA; Kuznetsova SA; Kiseleva EP; Freĭdlin IS Vopr Onkol; 2009; 55(5):603-7. PubMed ID: 20020657 [TBL] [Abstract][Full Text] [Related]
18. Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis. Xu K; Gao H; Shu HK Mol Cancer Ther; 2011 Jan; 10(1):138-47. PubMed ID: 21220497 [TBL] [Abstract][Full Text] [Related]
19. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]